IntegraGen Reports Revenue for First Half of 2015


IntegraGen today announced its sales for the first half 2015. Sales for IntegraGen’s business totaled € 2.6 million as of June 30, 2015, up 1% compared to the first half of 2014. The company also reported that it experienced a substantial growth in new projects during the first half of 2015 increasing by (…)  » 

AP-HP : Georges Pompidou European Hospital and IntegraGen announce a cooperation agreement for access to a high-throughput sequencing platform


IntegraGen and the Georges Pompidou European Hospital (HEGP) announce the signing of an agreement to develop the use of high-throughput sequencing techniques to improve the care of patients.

Click here to view press release.

#content-main{display:none} For full functionality of this site it is necessary to enable JavaScript. Here (…)  » 

IntegraGen presents positive data from two new studies on miR-31-3p biomarker at ASCO 2015


Results from two new studies exploring the role of the microRNA biomarker miR-31-3p in patients with metastatic colorectal cancer were presented during the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting. The studies reported positive results on the association between miR-31-3p expression and clinical outcomes in metastatic colorectal cancer (mCRC) patients treated with (…)  » 

Institut Pasteur and IntegraGen announce alliance

The Institut Pasteur and IntegraGen today announced the signing of a partnership agreement making IntegraGen the the operator of sequencing activities for the National Reference Centres (NRC) and microbiological collections of the Institut Pasteur.

Link to press release

#content-main{display:none} For full functionality of this site it is necessary to enable JavaScript. (…)  »